EDUCATIONAL WEBINAR: Evidence-Based Strategy in the Prevention of Complications due to Retained Blood

An Educational Webinar with Presenters: Marc Gillinov, MD, Marc Gerdisch, MD, and Alyson Mehringer, RN discussing the basic principles of Chest Tube Management, the results of a 1 year quality improvement study and the operational perspective from the ICU Nursing Staff.



ClearFlow Employees Make a Stand For Heart Health At The American Heart Association’s Annual Heart & Stroke Walk & 5K Run

Anaheim, CA – March 10, 2015—ClearFlow Inc., a medical device company based in Anaheim, CA, rallied its employees, their families and loved ones this past weekend in the name of heart health awareness for the American Heart Association’s 34th Annual Heart & Stroke Walk & 5K Run starting and finishing at Angel Stadium of Anaheim.

Most of ClearFlow’s growing organization was represented at the event, with employees and their families getting involved to raise money for the good cause.

“While our day to day efforts specifically focus on improving outcomes of cardiovascular and cardiothoracic procedures,” said ClearFlow President & CEO, Paul Molloy. “Heart health, improved quality of life and healthier lifestyles overall are at the very core of our mission. It makes sense for us to rally our team in support of the AHA and their likeminded initiatives.  We’re proud to have been able to support such an important event, cause and education-based endeavor.”

ClearFlow’s innovative PleuraFlow® Active Clearance Technology® System  uses a first of its kind technology to enable caregivers to proactively keep chest drainage tubes clear of blood clotting after heart surgery.  A common issue in hospitals, chest tube obstruction is known to occur in 36% of heart surgery patients, and nearly one in five can have some form of complication that includes the need to perform subsequent re-operation or interventions to remove blood, blood clot or bloody fluid from the pericardial or pleural spaces after cardiac surgery. These complications are referred to as Retained Blood Syndrome (RBS).

Procedures to remove retained blood are the most common invasive reinterventions after heart surgery and postoperative atrial fibrillation is the most common complication after heart surgery.  Recent results reported from a large German heart center showed that PleuraFlow significantly lowered these common and expensive hospital complications.

The PleuraFlow Active Clearance Technology System is approved for use in the U.S., Europe, Australia, Brazil, and Canada, and has either cleared or Is pending clearance in over a dozen more countries.

About ClearFlow, Inc.

ClearFlow, Inc. is an Anaheim, CA based medical device company that has developed a patented active blood and fluid evacuation system to speed recovery, reduce complications and lower healthcare costs. The company has been awarded several prestigious awards, including the European Association of Cardiothoracic Surgeons Techno-College Innovation Award for worldwide innovation that has the potential to change the standard of care in heart and lung surgery, the Innovations in Cardiovascular Interventions Award and the Gold Medical Design Excellence Award as well as the International Medical GOOD DESIGN Award, among others.


PleuraFlow and Active Clearance Technology are registered trademarks of ClearFlow, Inc.

Media Contact:
Paul Williams